BioXcel Therapeutics
(NASDAQ:BTAI)
BioXcel Therapeutics, Inc. - Common Stock is expected to split Monday, August 15, 2022 with a ratio of 1:5
BioXcel Therapeutics, Inc. - Common Stock recently split on Friday, August 12, 2022 with a ratio of 1:3
$15.64
0.47[3.10%]
At close: Aug 12
$15.69
0.0500[0.32%]
After Hours: 5:38PM EDT
Day High/Low15.12 - 15.94
52 Week High/Low8.8 - 24.57
Open / Close15.29 / 15.64
Float / Outstanding14.8M / 28M
Vol / Avg.307.4K / 523.5K
Mkt Cap438.3M
P/E-
50d Avg. Price13.97
Div / Yield-
Payout Ratio-
EPS-1.12
Total Float14.8M

BioXcel Therapeutics (NASDAQ:BTAI), Quotes and News Summary

BioXcel Therapeutics (NASDAQ: BTAI)

Day High/Low15.12 - 15.94
52 Week High/Low8.8 - 24.57
Open / Close15.29 / 15.64
Float / Outstanding14.8M / 28M
Vol / Avg.307.4K / 523.5K
Mkt Cap438.3M
P/E-
50d Avg. Price13.97
Div / Yield-
Payout Ratio-
EPS-1.12
Total Float14.8M
Sector: Health Care.Industry: Biotechnology
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501, and BXCL701.

Earnings

see more
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-12-20
REV
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-11-09
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

BioXcel Therapeutics Questions & Answers

Q
How do I buy BioXcel Therapeutics (BTAI) stock?
A

You can purchase shares of BioXcel Therapeutics (NASDAQ: BTAI) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are BioXcel Therapeutics's (BTAI) competitors?
Q
What is the target price for BioXcel Therapeutics (BTAI) stock?
A

The latest price target for BioXcel Therapeutics (NASDAQ: BTAI) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting BTAI to fall to within 12 months (a possible -74.42% downside). 50 analyst firms have reported ratings in the last year.

Q
Current Stock Price for BioXcel Therapeutics (BTAI)?
A

The stock price for BioXcel Therapeutics (NASDAQ: BTAI) is $15.64 last updated August 12, 2022, 8:00 PM UTC.

Q
Does BioXcel Therapeutics (BTAI) pay a dividend?
A

The next BioXcel Therapeutics (BTAI) dividend date is projected to be Thursday, September 1, 2022.

Q
When is BioXcel Therapeutics (NASDAQ:BTAI) reporting earnings?
A

BioXcel Therapeutics’s FY earnings are confirmed for Wednesday, December 20, 2023.

Q
Is BioXcel Therapeutics (BTAI) going to split?
A

There is no upcoming split for BioXcel Therapeutics.

Q
What sector and industry does BioXcel Therapeutics (BTAI) operate in?
A

BioXcel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.